Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
11/07/2023 06:42
July 11 (Reuters) - TheraVet SA ALVET.PA :
* THERAVET PROVIDES UPDATE ON ITS 2023 HALF-YEAR DEVELOPMENT
AND
PORTFOLIO STRATEGY
* WE EXPECT SECOND HALF OF YEAR TO BE AS SUCCESSFUL AS FIRST
HALF
- CEO
* AVAILABLE CASH ON JUNE 30, 2023, IS EUR 1.7 MlN COMPARED
TO EUR
3.5 MLN ON JUNE 30, 2022
Source text for Eikon: ID:nBw4dwFT2a
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Theravet SA
See all newsBrief: Theravet Announces Setting Up Of An Equity-Linked Financing Facility
Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
Brief: Theravet End-Dec Cash Position Of EUR 3.19 Mln
Brief: Theravet Signs New Distribution Agreement For Its Biocera-Vet With Elvetis